Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | VNN1 | O95497 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25287803 | 0.89 | CA2 (0.67) | CA2CA12CA1CA7CA9 | |
| SCHEMBL25793100 | 0.88 | CA2 (0.51) | CA2CA12CA1CA7CA9 | |
| SCHEMBL25794822 | 0.87 | CA2 (0.50) | CA2CA12CA1CA7CA9 | |
| SCHEMBL25794676 | 0.81 | CA2 (0.78) | CA2CA12CA1CA7CA9 | |
| SCHEMBL30524782 | 0.81 | VNN1 (0.49) | CA2ALDH1A1L3MBTL1VNN1 | |
| SCHEMBL20826227 | 0.74 | CA2 (0.42) | CA2ALDH1A1 | |
| SCHEMBL5540004 | 0.74 | ALDH1A1 (0.67) | CA2ALDH1A1L3MBTL1TDP1 | |
| SCHEMBL10770322 | 0.74 | ALDH1A1 (0.51) | ALDH1A1VNN1 | |
| SCHEMBL13804371 | 0.72 | ALDH1A1 (0.53) | CA2ALDH1A1L3MBTL1 | |
| SCHEMBL6275232 | 0.71 | ALDH1A1 (0.60) | CA2ALDH1A1L3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023133507-A1 | ESTRADIOL PRODRUGS AND METHODS OF USE THEREOF | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2023-07-13 | — | — | WO | disclosed |